Results
General patients’ characteristics and comorbidities
As shown on Fig.
1, records for 557 DM patients and 987 TB Patients were analysed in this study. 10.6% (n = 105) of the total 987 TB patients, and 11.5% (n = 64) of the total 557 PWDs were treated in the integrated clinic. There was a male predominance in the TB patient group (69.5%; n = 686) and a female predominance in the PWDs (58.0%; n = 323), which was similar in both the integrated and non-integrated setting.
TB patients were younger than PWDs (mean age 41 and 54 years, respectively) as shown on Table
1 and in Additional file
1: Table S1. 107/557 (19.2%) of the PWDs had Type 1 diabetes, 39/987 (4.0%) of the TB patients had MDRTB; see Table
2. 259/557 (46.5%) PWDs were hypertensive, 9.2% of PWDs had cardiovascular diseases whereas renal diseases were the least prevalent condition among PWDs (1.4%). On risk factors, 8/463 (1.7%) of the PWDs were smokers, 15/455 (3.3%) consumed alcohol, 89/198 (45.0%) consumed fruits and vegetables less than two times a week and 91/221 (41.2%) make less than two 30-min exercise sessions per week, respectively. Differences between integrated and non-integrated hospitals on PWDs performing daily 30 min of exercises involving planned activities such as jogging or walking sessions performed in the week as defined by WHO [
33] or consumption of at least three or more times of fruits and vegetable portions per week were not significant, of course, with high percentages of missing records for these variables as seen on Table
2.
Table 1
Background characteristics of patients seen at both integrated and non-integrated hospitals
TB Patients' Categories | New | 863 (87.4%) | 90 (85.7%) | 773 (87.6%) |
Failed | 4 (0.4%) | 0 (0.0%) | 4 (0.5%) |
Treatment after loss to follow up | 10 (1.0%) | 1 (1.0%) | 9 (1.0%) |
Relapse | 96 (9.7%) | 14 (13.3%) | 82 (9.3%) |
TB Type | Extra-Pulmonary | 263 (26.6%) | 50 (47.6) | 213 (24.1%) |
| Pulmonary | 724 (73.4%) | 55 (52.4%) | 669 (75.9%) |
MDRTB | Yes | 39 (4.0%) | 1 (1.0%) | 38 (4.3%) |
| No | 948 (96.0%) | 104 (99.0%) | 844 (95.7%) |
Sex | Female | 301 (30.5%) | 39 (37.1%) | 262 (29.7%) |
| Male | 686 (69.5%) | 66 (62.9%) | 620 (70.3%) |
TB Patients with available information on age | (N = 932) | (n = 97) | (n = 835) |
Age distribution | Mean, Median (Min; 1stq; 3rdq; max) | 41.1,38.0 (15,30,48,89) | 47.1,43.0 (15,38,60,83) | 40.4, 38.0 (15,29,46,89) |
≤ 25 years | 150 (16.1%) | 12 (12.4%) | 138 (16.5%) |
26–40 Years | 398 (42.7%) | 31 (32.0%) | 367 (44.0%) |
41–49 Years | 169 (18.1%) | 18 (18.6%) | 151 (18.1%) |
50–64 Years | 136 (14.6%) | 17 (17.5%) | 119 (14.3%) |
≥ 65 years | 79 (8.5%) | 19 (19.6%) | 60 (7.2%) |
DM Type | Type 2 | 450 (80.8%) | 50 (78.1%) | 400 (81.1%) |
Type 1 | 107 (19.2%) | 14 (21.9%) | 93 (18.9%) |
Years in Care Since Enrolment | ≤ 1 Year | 311 (55.8%) | 24 (37.5%) | 287 (58.2%) |
2 to 3 Years | 128 (23.0%) | 28 (43.8%) | 100 (20.3%) |
4 to 5 Years | 52 (9.3%) | 5 (7.8%) | 47 (9.5%) |
6 to 7 Years | 40 (7.2%) | 3 (4.7%) | 37 (7.5%) |
≥ 8 Years | 26 (4.7) | 4 (6.3%) | 22 (4.5%) |
Sex | Female | 323 (58.0%) | 35 (54.7%) | 288 (58.4%) |
| Male | 234 (42.0%) | 29 (45.3%) | 205 (41.6%) |
PWDs with available information on age | (N = 496) | (n = 64) | (n = 432) |
Age distribution | Mean, Median | 53.6,55 | 52.4, 51.5 | 53.8, 55 |
(Min; 1stq; 3rdq; max) | (15,43,65,87) | (16,41.5,63,87) | (15,44,65,87) |
≤ 25 years | 26 (5.2%) | 4 (6.3%) | 22 (5.1%) |
26–40 Years | 77 (15.5%) | 11 (17.2%) | 66 (15.3%) |
41–49 Years | 82 (16.5%) | 12 (18.8%) | 70 (16.2%) |
50–64 Years | 186 (37.5%) | 25 (39.1%) | 161 (37.3%) |
≥ 65 years | 125 (25.2%) | 12 (18.8%) | 113 (26.2%) |
Table 2
Comorbidities among TB patients and People living with DM and DM related complications
*HIV Infected | Yes | 372/908 (41.0%) | 50/104 (48.1%) | 322/804 (40.1%) |
| No | 536/908 (59.0%) | 54/104 (51.9%) | 482/804 (59.9%) |
HIV Infected | Yes | 34 (6.1%) | 10 (15.6%) | 24 (4.9%) |
| No | 523 (93.9%) | 54 (84.4%) | 469 (95.1%) |
Hypertension (HTN) | Yes | 259 (46.5%) | 27 (42.2%) | 232 (47.1%) |
| No | 298 (53.5%) | 37 (57.8%) | 261 (52.9%) |
Cardiovascular Diseases | Yes | 51 (9.2%) | 9 (14.1%) | 42 (8.5%) |
No | 506 (90.8%) | 55 (85.9%) | 451 (91.5%) |
Peripheral Heart Diseases | Yes | 13 (2.3%) | 5 (7.8%) | 8 (1.6%) |
No | 544 (97.7%) | 59 (92.2%) | 485 (98.4%) |
Retinopathy | Yes | 14 (2.5%) | 9 (14.1%) | 5 (1.0%) |
| No | 543 (97.5%) | 55 (85.9%) | 488 (99.0%) |
Renal Disease | Yes | 8 (1.4%) | 7 (10.9%) | 1 (0.2%) |
| No | 549 (98.6%) | 57 (89.1%) | 492 (99.8%) |
Stroke /TIA | Yes | 15 (2.7%) | 10 (15.6%) | 5 (1.0%) |
| No | 542 (97.3%) | 54 (84.4%) | 488 (99.0%) |
Neuropathy | Yes | 32 (5.8%) | 16 (25.0%) | 16 (3.3%) |
| No | 525 (94.2%) | 48 (75.0%) | 477 (96.7%) |
Sexual dysfunction | Yes | 9 (1.6%) | 7 (10.9%) | 2 (0.4%) |
No | 548 (98,4%) | 57 (89.1%) | 491 (99.6%) |
*Smoking ( PWDs with available information = 463) | Yes | 8 (1.7%) | 2 (3.2%) | 6 (1.5%) |
No | 455 (98.3%) | 61 (96.8%) | 394 (98.5%) |
*Alcohol Consumption (PWDs with available information = 455) | Yes | 15 (3.3%) | 3 (4.9%) | 12 (3.1%) |
No | 440 (96.7%) | 58 (95.1%) | 382 (97.0%) |
*Fruit / Vegetable Portions per week (PWDs with available information = 198) | ≥ Three Times | 109 (55.0%) | 5 (25.0%) | 104 (58.4%) |
≤ Two Times | 89 (45.0%) | 15 (75.0%) | 74 (41.6%) |
*Frequency of daily 30 min of exercise per week (PWDs with available information = 221) | ≥ Three Times | 130 (58.8%) | 19 (73.1%) | 111 (56.9%) |
≤ Two Times | 91 (41.2%) | 7 (26.9%) | 84 (43.1%) |
Table 3
Screening coverages and TB/ DM Comorbidities among TB patients and People with DM
A. Tuberculosis Patients | |
Variables | Category | Totals n = 987 (100%) | Integrated site n = 105 (10.6%) | Non-Integrated sites n = 882 (89.4%) | RD (%) (95%CI) |
DM Screening and DM Comorbidities among TB Patients |
TB patients screened for DM | 53 (5.4%) | 10 (9.5%) | 43 (4.9%) | 4.6% (-1.1,10.4) |
Diagnosed DM Cases amongst the screened TB Patients, and of the total TB patients |
DM among screened TB Patient | 5/53 (9.4%) | 1/10 (10.0%) | 4/43 (9.3%) | | |
DM among total TB Patients | 5/987 (0.5%) | 1/105 (1.0%) | 4/882 (0.5%) | | |
Screening of TB among People with Diabetes mellitus (PWD) | |
PWD screened for TB | 41 (6.6%) | 36 (56.3%) | 5 (1.0%) | 55.2 (43.0,67.4) |
Diagnosed TB Cases amongst the screened people with DM, and of the total People with DM |
Pulmonary | 3 /41 (7.3%) | 1/36 (2.8%) | 2/5 (40.0%) | | |
Extra-Pulmonary | 2/41 (4.9%) | 0 | 2/5 (40.0%) | | |
TB cases of Screened PWD | 5/41 (12.2%) | 1/36 (2.8%) | 4/5 (80.0%) | | |
TB cases of total recruited PWD | 5/557 (0.9%) | 1/64 (1.6%) | 4/493 (0.8%) | | |
TB and DM Screening coverage of both PWD and TB cases
On Table
3, 10/105 (9.5%) TB patients were screened for DM in integrated care while 43/882 (4.9%) were screened for DM in non-integrated care setting, RD 4.6, 95%CI (− 1.1, 10.4), P = 0.065 respectively. Of the total TB patients screened, 5/53 (9.4%) were diagnosed with DM. Among PWDs, 36/64 (56.3%) were screened for TB in integrated care setting as compared to 5/493 (1.0%) in the traditional non-integrated care delivery system care RD 55.2%, (95%CI 43.0, 67.4), P < 0.001, and 5/41 (12.2%) of the screened DM patients were diagnosed with TB.
Treatment outcomes, glucose monitoring and retention into care
As shown on Table 4, 71/508 (14.0%) TB patients were lost to follow-up in non-integrated care hospitals, while in an integrated care, none were lost to follow-up in integrated care; RD -14.0%, (95%CI: -17.0,-11.0), p < 0.001, and TB treatment success was 92.5% in integrated cares, while in non-integrated care the treatment success was 78.5%, RD 14, (95%CI 7.6, 20.4); P = 0.001.
Among people with DM, 2/64 (3.1%) experienced loss to follow up in integrated care and 40/493 (8.1%) in non-integrated care, RD -5.0%, (95%CI: -10.0, -0.0%); P = 0.046.
On retention into care by PWD, 52/64 (81.3%) PWD in integrated care were in care for ≤ 3 years while in traditional non- integrating setting 387/493 (78.5%), RD 2.8%, 95%CI (-7.5, 13.0), P = 0.630 were recorded. Furthermore, aggregated data on Table
4 shows that after ≥ 2 years of follow up, 62.5% PWDs in integrated and 41.8% PWDs in non-integrated care were retained in care, RD 20.7, (95%CI: 8.1, 33.4), P = 0.001.
Table 4
Treatment Loss to follow up and treatment outcomes for TB patients, and Treatment Loss to follow up, Glucose monitoring and Retentions into Care by people living with DM
Treatment Outcomes | | | | | |
Treatment Loss to follow up | 71 (11.8%) | 0 | 71 (14.0%) | -14.0 (-17.0,-11.0) | - |
Treatment Success | 486 (80.7%) | 87 (92.5%) | 399 (78.5%) | 14.0 (7.6,20.4) | 14.3 (10.7,17.8) |
Died | 45 (7.5%) | 7 (7.4%) | 38 (7.5%) | -0.1 (-3.2,3.1) | -0.4 (-3.5,2.8) |
B. People with Diabetes mellitus | |
| Total: N = 557 (100%) | Integrated care: n = 64 (11.5%) | Non-Integrated care: n = 493 (88.5%) | RD (%) (95%CI) | RD (%) (95%CI) as controlled by both Sex and Age |
Treatment outcomes Outcome | |
On treatment & transferred out | 508 (91.2%) | 61 (95.3%) | 447 (90.7%) | 4.6 (-1.1,10.4) | 5.0 (-1.1,11.1) |
Loss to follow up & stopped | 42 (7.5%) | 2 (3.1%) | 40 (8.1%) | -5.0 (-10.0,-0.0) | -5.3 (-10.4,0.0) |
Died | 7 (1.3%) | 1 (1.6%) | 6 (1.2%) | 0.4 (-2.8, 3.5) | 0.3 (-3.1, 3.7) |
Quarterly FBG Checks (n, %) |
FBS checked at 6 months | 153 (27.5%) | 27 (42.2%) | 126 (25.6%) | 16.6 (4.7,28.5) | 16.4 (4.5,28.4) |
FBS checked at 12 months | 138 (24.8%) | 32 (50.0%) | 106 (21.5%) | 28.5 (15.3,41.7) | 28.1 (15.4,40.9) |
Years in Care Since Enrolment (n, %) |
≤ 1 Year | 311 (55.8%) | 24 (37.5%) | 287 (58.2%) | -20.7 (-33.4,-8,1) |
2 to 3 Years | 128 (23.0%) | 28 (43.8%) | 100 (20.3%) | 23.5 (10.8,36.1) |
4 to 5 Years | 52 (9.3%) | 5 (7.8%) | 47 (9.5%) | -1.7 (-8.8,5.4) |
6 to 7 Years | 40 (7.2%) | 3 (4.7%) | 37 (7.5%) | -2.8 (-8.5,2.9) |
≥ 8 Years | 26 (4.7) | 4 (6.3%) | 22 (4.5%) | 1.8 (-4.4,8.0) |
On blood glucose monitoring, 27/64 (42.2%) PWDs were checked for fasting blood glucose (FBG) assessment at 6 months at an integrating hospital, and 126/493 (25.6%) were checked at non-integrating hospitals RD 16.6%, (95%CI: 4.7,28.5), P = 0.005, while at 12 months; 32/64 (50.0%) were checked at integrating hospital while 106/493 (21.5%) were checked at non-integrating hospitals, 95%CI (15.3,41.7), P < 0.001, respectively (table
4). Additionally, 423/493 (85.8%) of PWD had their weights checked after 6 months into care at an integrated care hospital, while 28/64 (43.8%) were checked during the same period in non-integrated care hospitals.
Effects of integrated care on Treatment Success and mortality among TB patients, and Treatment Loss to follow up and or Stopped and quarterly FBG checks among people with DM as stratified as controlled by sex and age
After controlling for age and sex, as shown on Table
5, we observed that both sex and age of the patients did not significantly affect the association that was observed between integration status and bidirectional screening and treatment outcomes. However, on screening, the calculated crude risk ratio (RR) was RR1.9, 95%CI 0.2,20.1), while after controlling for sex and age, RR was increasing, but not significantly different as shown by RR2.2, (95%CI: 0.2,24.5). On the other hand, among PWDs, we found that PWDs were more likely to have FBG checked at 12 months in integrated care than in hospitals without integrating measures; RR2.3, 95%CI 1.2,4.5, and the results were statistically significant. Like results in screening, the crude RR did not significantly change after controlling for sex and age.
Table 5
Showing association between integrated care and Treatment Success and mortality among TB patients, treatment loss to follow up and or stopped and Quarterly FBG checks among DM patients as controlled by sex, age and both age and sex
Treatment Outcomes among TB patients |
Treatment Success | 1.8 (1.2,2.7) | 1.8 (1.2,2.7) | 1.8 (1.2,3.0) | 1.8 (1.2,2.8) |
Died TB Patients | 1.6 (0.1,24.6) | 1.5 (0.1,29.1) | 1.6 (0.1,26.2) | 1.6 (0.1,30.1) |
Probability of screening TB patients for DM |
Screening Likelihood | 1.9 (0.2,20.1) | 1.9 (0.2,19.4) | 2.1 (0.2,25.0) | 2.2 (0.2,24.5) |
Treatment Outcomes among DM patients |
Loss to follow up, stopped | 0.4 (0.1,1.7) | 0.4 (0.1,1.7) | 0.4 (0.1,1.6) | 0.4 (0.1,1.6) |
Quarterly Fasting Blood Glucose (FBG) Checks |
FBS checked at 6 months | 1.6 (1.0,2.7) | 1.7 (1.1,2.8) | 1.6 (1.0, 2.7) | 1.7 (1.0, 2.7) |
FBS checked at 12 months | 2.3 (1.2,4.5) | 2.4 (1.3,4.6) | 2.3 (1.2,4.3) | 2.4 (1.3,4.3) |
Discussion
With an increasing global prevalence of TB and DM comorbidity, integrated approaches to care for effective management of both diseases especially in LMICs where heath systems are weak, TB is endemic, and where 80% of global type 2 DM are found [
7] have been recommend. In this study, we found that 9.4% of the screened TB patients were living with DM which is suggesting high prevalence of TB among DM patients and high DM among TB patients than in general population in Malawi where prevalence of DM is approximately 5.6%, hypertension is 33%, HIV infections is 9.0% [
18,
34], and that of TB is 181 (113–265) per 100,000 [
24]. Furthermore, our findings support results from several other observational studies that were conducted in a few LMICs countries such as South Africa, Romania, China, Peru, Indonesia and India [
12,
13,
35‐
40] where 10.9%, 12.3, 14.0%, 19.7%, 14.0% and 24% prevalence of DM among TB patients were reported respectively. These results support the estimated high global TB and DM comorbidities where one million out of 9.6 million annual TB cases (10.4%) are estimated to be living with DM [
6]. With such high prevalence of TB and DM comorbidity, WHO, IUATLD and IDF [
12‐
14] are recommending adoption of TB/DM integrated approach to services delivery, however, each country should consider specific epidemiology of both TB and DM and strength of health systems.
Screening coverage for DM among TB patients in integrated settings was nearly 2 times that in non-integrated settings, but this only meant an overall increase from 4.9 to 9.5% and is less than what would be needed to generate wider impact. Nevertheless, low screening coverage and low yields, in our study, might have been attributed to barriers in implementation of integrated care program. For instance, two implementation research studies from Mexico and China [
39,
40] found that shortages of human and materials resources are among factors that affected the outcomes of the integrated care services in their pilot sites. These challenges are inevitable in Malawi, a poor country, like other countries in Sub-Saharan Africa (SSA), with a critical shortage of healthcare workers [
41]. In addition to human resource shortages, observational studies that were conducted in India [
42,
43] found that other factors such as patients perspectives, recording system and lack of supplies and laboratory equipment like glucometers and testing strips may affect implementation of integrated screening services in hospitals. Thus, governments in Africa are advised to consider improving health systems for effective management of the increasing numbers of NCDs such as DM [
44]. Irrespective of the underlying reasons for low screening coverage of DM in TB patients, our results indicate that within implementation of integrating care it is important to measure screening coverage and make efforts to increase it.
On treatment outcomes, we found less treatment loss to follow up in integrated care than in non-integration, and better TB treatment success in integrated care than in traditional non-integrated care even after controlling for both sex and age. The findings agree with those of an implementation research study that was conducted in Mexico [
40] which showed that joint management of TB and DM comorbid patients reported lower proportions of treatment loss to follow up and increased treatment success than in non-integrated care system. In another study that was conducted in Taiwan [
45], it was found that enhanced case management of PWDs on a Pay-4-Performacne program (p4p) contributed to reduced annual incidence rate of TB to 137.5/100,000 in DM-p4p group as compared to 259.9/100,000 in DM-non-p4p. Furthermore, the same study reported an improvement in TB treatment outcomes among TB patients with DM in DM-p4p program as compared to DM-non-p4p program.
In this study, retrospective follow up of PWDs for 12 months into care program showed high retention rate among PWDs in integrated care than in non-integrated care. Studies have shown that retention into care helps to ensure glucose monitoring and early identification of complications. For instance, Harries et al. [
3] found that inadequate glucose monitoring, under diagnosis, inadequately treated and poorly controlled DM appears to be a much greater threat to TB care and prevention than previously realized, and the authors further reported that the problem of uncontrolled glucose among DM patients is critical in poor countries.
On DM related complication, we found more records of complications in the integrated hospital than in non-integrating hospitals a situation which could suggest reverse causality [
46] since integrated care might have contributed to increased and improved diagnosis of DM complications in the integrated clinic. Therefore, the observed association might have been attributed to effects of integrated clinic services where more conditions could be identified than in non-integrated hospitals. On the other hand, background differences in the study sites and study participants might have confounded the results.
During the study, one hospital was integrating, and this hospital was compared against seven other hospitals which applies traditional or non-integrated method. This integrating hospital is supported by an international organisation; Partners in Health (PIH), which has contributed to health systems strengthening through capacity building by providing materials and employing of additional healthcare workers at the Integrated NCD clinic [
15]. Therefore, if TB and DM integrated care services are to be scaled up to other hospitals in Malawi, lessons from this piloting hospital should be carefully considered. Furthermore, considerations should be made on the actual activities to integrate, availability of supplies and staff at a standard district hospital, level of integration within the health system and how the impact of the integration on the efficiency of services delivery shall be monitored [
47].
Study strengths and limitations
The introduction of the treatment cards made this study possible. However, hospitals experienced shortage of treatment cards such that patients, in some instances, were being recorded in improvised notebooks, and that these cards did not have all the data elements on TB patient records. For instance, data on diagnostics tests that were performed to confirming the cases was not collected since such information is not recorded on the cards. Furthermore, high proportion of data from patients who were still on treatment were collected due to missing data of the old records, and that the improvised notebooks could not capture all needed data elements as indicated on the card. In addition to shortage of treatment cards, we found many cards with blank spaces which contributed to high proportion of missed data. Apart from other general standards for secondary level of care at district hospitals in Malawi, Neno had additional staff employed by the NGO, which is supporting the integrated NCDs clinic. Furthermore, small sample size especially from the integrated care since one hospital was integrating at the time when data collection was performed, and that socio-economic characteristics of both TB patients and PWDs in all non-integrating hospitals might not have been like those at the integrating hospital. Additionally, we included more TB patients who were still on treatment due to availability of records and missing data in the past records, such that less TB records were analysed on treatment outcomes.
Conclusions
We found that in one setting with efforts of integrated care compared to seven without these efforts TB screening for DM patients is increased, that treatment loss to follow up in both diseases is reduced, and treatment success among TB patients is improved with TB/DM integration measures, but only limited evidence on the increase of DM screening for TB patients. Therefore, decisions on hospitals to integrate TB/DM should be taken considering burden of the disease, and the currently rather weak evidence of an effect on bidirectional screening coverage and treatment outcomes of both diseases, and the barriers faced in the local context as well as existing guidelines.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.